Hunting with a crossbow, a type of archery weapon, is a versatile and effective method for pursuing small and large game, as well as for bowfishing. Representing a hybrid between a rifle and a bow, a ...

Archery deer season starts statewide Saturday, and bowhunters are excited about embarking on the nation's longest continuous ...

Australia’s Mosaic Oil is taking a slice of Bow Energy’s exploration play in the south-western Surat basin after agreeing multi-stage farm-ins with fixed and optional wells. The farm-in blocks, ...

Not all oil is the same when it comes to string trimmers. Different types of motors require different levels of oil viscosity ...

Oil futures finished with a loss on Friday, with U.S. and global benchmark prices ending a streak of weekly gains, as investors juggled recession fears and concerns over demand. Myra P. Saefong, ...

Udupi: Daily travel between Udupi, the temple town, and Manipal, one of the premier education hubs in the country, will now become easier with the inauguration of the long-awaited Bow String Girder ...

Oil futures are treading water after rising the previous three sessions on concerns about Russian supply disruptions, with market moves limited ahead of the Fed's interest-rate decision. The API ...

It’s not difficult to find a crossbow that shoots arrows over 450 fps and 3-inch groups at 50 yards, especially if price is of no concern. But finding an accurate, easy-to-use, and feature-rich ...

The Springboks are confident despite the All Blacks’ undefeated streak at Eden Park. The Rugby Championship clash is hotly anticipated, both rugby heavyweights having shown vulnerability with a loss ...

In a show of confidence in the market, the group, led by Saudi Arabia, said it would begin unwinding a further set of agreed cuts. By Stanley Reed Oil prices rose strongly on Monday even though a ...

Novartis has another phase 3 trial win in its quiver for targeted factor B inhibitor iptacopan, building the case for the drug as a new oral therapy for diseases caused by disorders of the complement ...

Johnson & Johnson has reported new phase 3 data with its FcRn blocker nipocalimab in generalised myasthenia gravis (gMG), pointing to data that it says differentiates it from other drugs in the class.